Case Study

Extractables And Leachables Studies Support Single-Use Systems

Source: Nitto Avecia Pharma Services

By Aryo Nikopour, Senior Vice President, Scientific & Technical Services, Nitto Avecia Pharma Services

Extractables And Leachables Studies Support Single-Use Systems

Single-use systems have gained a surprisingly strong foothold in the drug manufacturing market thanks to improved extractables and leachables studies.

Not long ago, concerns about leachables were expected to restrict adoption of single-use systems.

2015 Survey Found Limited Interest in Disposable Systems

One of the most widespread concerns in the biopharmaceutical industry in 2015 was plastics and their additives, by-products, and other non-fully-polymerized polymer and formulated plastics’ leachables affecting bioprocessing and related products.1

The 2015 BioPlan Report and Survey of Biopharmaceutical Manufacturers found three-quarters of respondents agreed or strongly agreed that this concern limited their adoption of single-use systems.

Yet three years later, the same annual survey found high adoption rates for these disposable systems. It appears the worries had vanished.

Concerns about leachables were expected to restrict adoption of single-use systems. This case study shows how far they’ve come.

 

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: